Delivery Order SPE2DB25D3201-SPE2DB25FNVVC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Mycophenolate 500 mg tablets (500 count) valued at $1,676.36. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,219.46 delivery order to AmerisourceBergen Drug Corp for Mycophenolate 500 mg tablets (100 count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract—which includes no set-aside designation—represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.68 to AmerisourceBergen Drug Corp for Mycophenolate 200 mg/ml suspension in 160 ml quantities. The contract, awarded July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under a competitive procurement process, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,919.79, is for the delivery of 500 units of Mycophenolate 250 mg capsules. It is a firm fixed-price delivery order contract with a completion date of June 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,296.65 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mycophenolate 200 mg/ml suspension in a 160 ml quantity, with completion targeted for July 28, 2025. This firm fixed price contract represents a non-competitive set-aside award to the pharmaceutical distributor's corporate office, with performance to be executed in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYCOPHENOLATE 500 MG TABLET 500S. The contract, valued at $1,388.16, has a completion date of February 23, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Mycophenolic Acid DR 360 mg Tablets (120 count). The order has a potential value of $1,660.86 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and the product will be delivered from the company's facilities in Conshohocken, Pennsylvania. This delivery order is part of a...
- This is a $1,876.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for MYCOPHENOLATE 500 MG TABLET 500S, a prescription medication, with a completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,520.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S to Conshohocken, PA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S and has a ceiling value of $1,299.65. The order has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVVCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,284.84 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 250 mg capsules (500 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract number SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The broader contract encompasses a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The delivery order for Mycophenolate, an immunosuppressive medication, exemplifies the routine pharmaceutical procurement activities executed through this prime vendor arrangement, which supports military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/21/25 |